Key Points - The stock price of Zhonghong Medical (300981) closed at 12.93 yuan on February 5, 2026, with a slight increase of 0.31% and a turnover rate of 0.6% [1] - The trading volume was 23,600 shares, with a total transaction amount of 30.4488 million yuan [1] Trading Information Summary - On February 5, 2026, the net inflow of main funds was 232,200 yuan, while the net inflow of speculative funds was 1.8918 million yuan; retail investors experienced a net outflow of 2.124 million yuan [1][3] Company Announcement Summary - Zhonghong Medical held its first extraordinary general meeting of shareholders for 2026 on February 5, 2026, where three proposals were approved: 1. Investment of idle self-owned funds in low-risk financial products for 2026 2. Conducting foreign exchange derivative trading for 2026 3. Engaging in commodity futures hedging business and related transactions for 2026 - All proposals were passed with the related shareholders abstaining from voting on the related transaction proposal [1][3] - A legal opinion from Beijing Deheng Law Firm confirmed the legality and validity of the meeting's procedures and voting results [1]

Core Viewpoint - Shenzhen Zhengzhong Design Co., Ltd. plans to utilize idle self-owned funds to invest in low-risk financial products, aiming to enhance the efficiency of fund usage and generate returns for the company and its shareholders [2][3][20]. Investment Overview - **Investment Purpose**: The investment aims to improve the efficiency of idle funds and generate returns without affecting normal operations and maintaining controllable risks [3]. - **Investment Amount**: The company and its subsidiaries intend to use up to RMB 550 million of idle self-owned funds to purchase low-risk financial products, with the ability to recycle funds within this limit [2][4]. - **Investment Duration**: The investment is valid for 12 months from the date of approval by the board of directors [5]. - **Investment Method**: The investment will be made in various low-risk financial products issued by banks, securities companies, and trust companies, characterized by high safety and liquidity [6]. - **Source of Funds**: The funds for this investment will come from the company's and its subsidiaries' self-owned funds, without involving raised funds or bank credit [7]. Approval Process - The board of directors held the 18th meeting of the fifth session on February 3, 2026, where the proposal to use idle self-owned funds for financial product investment was approved [8][20]. - The decision was made with unanimous support from all attending directors, and the management was authorized to implement the investment [20]. Impact on the Company - The investment in low-risk financial products will not affect the company's normal cash flow or operational needs, and it is expected to enhance the efficiency of idle funds and provide returns for shareholders [14][20]. - The company will adhere to relevant accounting standards for financial instruments in its accounting and reporting [14].

Core Viewpoint - Zhengzhong Design announced plans to invest up to 550 million yuan in low-risk financial products issued by banks, securities companies, and trust companies, utilizing idle self-owned funds [1] Group 1: Investment Details - The investment will be made using the company's and its subsidiaries' own funds [1] - The investment limit is set to be available for recycling within 12 months [1] - The effective period for this investment plan starts from the date of approval by the fifth board of directors' eighteenth meeting, which is February 3, 2026 [1] Group 2: Approval Process - The investment plan has been approved by the company's board of directors [1] - There is no requirement for shareholder meeting approval for this investment decision [1]

Group 1 - The company announced on January 26 that it will hold the 18th meeting of the fifth board of directors on January 25, 2026, to review the proposal for using idle self-owned funds to purchase financial products [1] - The company and its subsidiaries are authorized to use up to 5 billion RMB of idle self-owned funds to invest in low-risk financial products with high safety and liquidity, provided it does not affect normal business operations [1] - The funds can be rolled over within the approved limit, and the investment period for individual products will not exceed 12 months [1]

Core Insights - The high-interest deposits are set to mature starting from October 2025, with a significant amount of funds, estimated to be in the tens of trillions, facing a critical decision point in 2026 [1][2] - The current downward trend in deposit rates has led to a shift in investment strategies among different risk-averse customer segments, with over half expected to reinvest in deposits while others may explore wealth management products and capital markets [1][2] Group 1: Market Dynamics - The concentration of high-interest deposit maturities is expected to peak in the first quarter of 2026, aligning with traditional banking practices for attracting new business [1] - The estimated scale of maturing high-interest deposits this year is projected to reach tens of trillions, indicating a substantial liquidity event in the market [2] Group 2: Customer Behavior - There is a notable divergence in product selection among customer groups based on their risk tolerance, with 50%-60% of maturing deposits likely to be reinvested in deposit products [2][3] - Customers prioritizing safety over yield are likely to convert maturing fixed deposits into demand deposits before potentially reinvesting in fixed deposits again [2] Group 3: Industry Response - Banks are undergoing a systemic transformation in response to the pressures of deposit outflows, focusing on product innovation and marketing strategies to retain customers [3][4] - The shift in assessment metrics from solely deposit volume to a broader asset management perspective encourages banks to prioritize comprehensive customer asset management [4] - Financial institutions are developing deposit-replacement products that offer better returns than traditional deposits, catering to clients willing to accept slight fluctuations in net value [4]

Trading Information - As of January 19, 2026, Zhonghong Medical (300981) closed at 13.39 yuan, up 0.75%, with a turnover rate of 0.89% and a trading volume of 34,900 shares, amounting to 46.4462 million yuan [1] - On January 19, 2026, the net outflow of main funds was 2.9472 million yuan, while retail investors saw a net inflow of 0.9156 million yuan [1] Company Announcements - Zhonghong Medical announced it will provide a guarantee of 50 million yuan for its wholly-owned subsidiary, Zhonghong International (Hong Kong) Trading Co., Ltd., in a financing contract with China Construction Bank [1] - The guarantee period is three years from the maturity of the main debt, and the subsidiary's latest asset-liability ratio is 94% [1] - The total guarantee amount for the company and its subsidiaries is 735 million yuan, accounting for 13.43% of the latest audited net assets, with no overdue guarantees [1] Board Meeting Resolutions - On January 19, 2026, Zhonghong Medical held its 16th meeting of the fourth board of directors, approving several proposals including the use of idle funds for low-risk financial products and foreign exchange derivatives trading [2] - The proposals will be submitted for approval at the first extraordinary shareholders' meeting of 2026, scheduled for February 5, 2026 [2] Financial Management Strategies - The company plans to invest up to 2 billion yuan of idle self-owned funds in low-risk financial products with a maximum investment period of 36 months [5] - The investment will focus on R1 and R2 rated financial products issued by commercial banks, trusts, and other financial institutions [5] - The company aims to conduct commodity futures hedging with a maximum trading margin of 5 million yuan and a total trading amount not exceeding 50 million yuan, using self-owned funds [3][4] Foreign Exchange Derivatives Trading - Zhonghong Medical intends to engage in foreign exchange derivatives trading to mitigate exchange rate risks, with a maximum balance of 500 million USD at any time [3][4] - The trading will include foreign exchange forwards, swaps, and options, with the funds sourced from self-owned capital [4]

Core Viewpoint - The company is focusing on utilizing idle funds for low-risk financial products rather than initiating a share buyback plan, emphasizing the importance of shareholder returns and efficient fund usage [1]. Group 1: Company Response to Investor Inquiry - The company acknowledges the importance of shareholder returns and states that the decision to invest idle funds in low-risk financial products is based on a phased financial plan and risk control requirements [1]. - The company assures that it will consider share buyback or increased dividends in conjunction with its financial status and development strategy, while adhering to information disclosure obligations [1]. - The investment in low-risk financial products is aimed at improving fund utilization efficiency and increasing cash asset returns [1].

Core Viewpoint - Anjie Technology (002635) is actively managing its financial strategies for 2026, including seeking a significant credit line and engaging in foreign exchange hedging to mitigate risks associated with overseas operations [1][2][3][4]. Group 1: Trading Information - On December 26, 2025, Anjie Technology's stock closed at 13.82 yuan, down 0.72%, with a turnover rate of 1.31% and a trading volume of 51,800 shares, amounting to a transaction value of 71.798 million yuan [1]. - The net inflow of main funds on the same day was 5.0859 million yuan, while retail investors saw a net inflow of 359,900 yuan, indicating mixed investor sentiment [1]. Group 2: Board Resolutions - The sixth board of directors held a special meeting on December 26, 2025, where they approved the estimated daily related party transaction limit for 2026, which is expected to total no more than 34 million yuan, representing 0.58% of the audited net assets for 2024 [1][2]. - The board also approved a proposal to apply for a comprehensive credit line of up to 5 billion yuan or its equivalent in foreign currency from banks and financial institutions for 2026 [2][3]. Group 3: Financial Strategies - Anjie Technology plans to conduct foreign exchange hedging activities from January 1, 2026, to December 31, 2026, with a total amount not exceeding 2 billion yuan or its equivalent in foreign currency, primarily involving USD [3][4]. - The company intends to utilize up to 2 billion yuan of idle self-owned funds for low-risk investment and wealth management, focusing on safe and liquid financial products [4].

Core Viewpoint - The company announced plans to invest up to 200 million RMB of its idle funds in low-risk financial products to enhance the efficiency and returns of its capital usage [1] Group 1: Investment Details - The board meeting will be held on December 18, 2025, to review the proposal for the investment [1] - The maximum single investment or project investment is capped at 50 million RMB [1] - The investment quota can be used on a rolling basis and is valid for 12 months from the date of board approval [1] Group 2: Authorization - The company’s chairman is authorized to sign relevant agreements and contracts within the specified investment range [1]

Group 1 - The core point of the article is that Aishida (SZ 002403) announced plans to invest up to 200 million RMB of its idle funds in low-risk financial products to enhance the efficiency and returns of its capital usage [1] - The investment will be capped at 50 million RMB per single investment or project, and the approval for this investment plan is valid for 12 months from the date of the board's approval [1] - As of the report date, Aishida's market capitalization stands at 4.2 billion RMB [1] Group 2 - For the first half of 2025, Aishida's revenue composition shows that industrial operations account for 96.83% while other businesses contribute 3.17% [1]